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The aim of the study was the evaluation of frequency and titre of IgA ASCA and IgG ASCA and p-ANCA, c-ANCA in children
with IBD and occurrence of ASCA antibodies in relation to coexistence of FA . Patients and methods. The study comprised 95
children at the ages of 2 to 18 years. The diagnosis of IBD was established on the basis of Porto criteria. Tests of blood serum were
performed in all children: IgA and IgG ASCA, p-ANCA, c-ANCA, using ELISA method. Results. IgE-dependent FA was found in
32.5%childrenwithUCandin21%withCD.WedidnotobserveanyrelationbetweentheoccurrenceofFAandthefrequencyand
ASCA titre. p-ANCA were signiﬁcantly more frequent in the group of children with UC. The occurrence of ASCA antibodies was
observed in 73.7% of children with CD, 17.5% with UC and almost 30% with allergic colitis. Conclusions. Patients with CD and
the presence of ASCA revealed a signiﬁcantly more frequent localization of lesions within the small bowel and a tendency towards
older age. We observed a connection between the occurrence of antibodies and the examined mutations of gene NOD2/CARD15.
Copyright © 2009 Urszula Grzybowska-Chlebowczyk et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Background
In the recent years we have observed not only an increased
incidence of Inﬂammatory Bowel Disease, especially Crohn’s
disease in children, but also other, less frequent in this age
group, types of colitis, including allergic colitis. Allergic
colitis is a rare type of inﬂammation occurring in the
course of IgE-mediated or IgE-independent food allergy,
more frequently it aﬀects children. This disease occurs in two
agegroups:ininfancyorduringpubertyandinyoungadults.
In the case of allergic colitis of adult type, clinical symptoms
depend on the degree of intensity and the localization
of inﬂammation—the predominant symptoms are those
that are typical for Inﬂammatory Bowel Disease—chronic
diarrhea, abdominal pain, loss of weight, and lack of appetite
[1, 2]. In endoscopy the mucosa may be free of any lesions
or may show non-characteristic inﬂammatory changes, such
as reddening, unclear vascular markings, or hypertrophy of
lymph nodules; the changes are often focal with eosinophilic
inﬁltration within the mucosa and sometimes with the
presence of multinuclear giant cells in the submucosa. In the
case of a big intensity of eosinophilic inﬁltration we call the
disease eosinophilic colitis [3].
Eosinophils occur not only in the course of allergic
colitis,butalsointhecourseofotherinﬂammatoryprocesses
involving the bowels as well as in drug-induced reactions
[4]. Both IBD and food allergy are the results of interactions
between immunologic, genetic and environmental factors.
Coexistence of food allergy is also frequently mentioned in
the course of ulcerative colitis and Crohn’s disease; many
studies also indicate a connection between allergiccolitis and
later development of IBD [5, 6].
ASCA antibodies against Saccharomyces cerevisiae and
ANCA antibodies against the cytoplasm of neutrophils have
been described since 1989, as being present in the serum
of patients with Inﬂammatory Bowel Disease, and now they
are considered to be a subclinical, genetic marker of a high
risk of development of Crohn’s disease and ulcerative colitis,
respectively. The frequency of ASCA antibodies is estimated
as 40%–70% in Crohn’s disease and 5%–20% in ulcerative2 Mediators of Inﬂammation
colitis, and the frequency of ANCA antibodies is estimated
as 40%–80% in ulcerative colitis and 15%–20% in patients
with Crohn’s disease, especially with involvement of the large
bowel (UC-like) [7–9].
ThereisaconnectionbetweenaclinicalphenotypeofCD
and ASCA—patients with a high titre of ASCA antibodies
in blood serum more frequently manifest a grave course of
disease with ﬁbrostenosis and perforations, which may be
associated with localization within the small bowel, whereas
no link between p-ANCA antibodies and the clinical picture
of ulcerative colitis was found [10].
On the basis of the current diagnostic methods, almost
10% of patients with Inﬂammatory Bowel Disease are ini-
tially wrongly classiﬁed. In the next 10%, the ﬁnal diagnosis
is diﬃcult to be established, and indetermined colitis is
diagnosed[11].ItseemsthatthedeterminationofASCAand
p-ANCA in various inﬂammatory bowel diseases will allow
to specify and establish the diagnosis.
The aim of the study was
(1) The evaluation of frequency and titre of antibodies
against Saccharomyces cerevisiae (IgA ASCA and
IgG ASCA) and anti-neutrophilic (p-ANCA and c-
ANCA) in children with various forms of Inﬂamma-
tory Bowel Disease.
(2) The evaluation of ASCA antibodies occurrence in
relationtocoexistenceoffoodallergyinchildrenwith
ulcerative colitis and Crohn’s disease.
2. Patientsand Methods
The study comprised 95 children at the ages of 2 to 18 years
(mean age 12.6), 78 with Inﬂammatory Bowel Disease and 17
with allergic colitis. The diagnosis of IBD was established on
the basis of Porto criteria (physical examination, laboratory
tests, immunological, radiological examinations, endoscopy
of the upper and lower part of the alimentary tract and
histopathological examinations) [12].
The examinations were carried out in the following
groups:
Group I-38 children with Crohn’s disease
Group II-40 children with ulcerative colitis
Group III-17 children with allergic colitis
Group IV-comparative-23 children with functional
disorders of the alimentary tract, the most fre-
quently caused by lactose intolerance, in whom
performed examinations excluded the inﬂammatory
background of reported complaints.
Tests of blood serum were performed in all children, in
both the examined and control groups:
(i) IgA and IgG ASCA—immunoenzymatic method
(ELISA), using reagents produced by Euroimmune
(norm up to 20RU/mL)
(ii) p-ANCA, c-ANCA—immunoenzymatic method,
using reagents produced by Biomedica (norm up to
3U/mL)
Table 1: Relation between the frequency of occurrence and titre of
ASCA antibodies and food allergy.
Allergy (+) Allergy (−) P
ASCA (IgG or IgA) in
whole examined group
40.8% 43.5% .84
ASCA (IgG or IgA) in UC 17.7% 17.4% 1.0
ASCA (IgG or IgA) In CD 80% 69.6% .71
Titre (median, range) IgA
ASCA in whole examined
group
7.7 (0–200) 9.1 (0–200) .69
IgG ASCA in whole group 10 (0–200) 10.1 (0–200) .96
IgA ASCA in UC 6.8 (0–200) 6.8 (0–200) .85
IgG ASCA in UC 5.4 (0–200) 4.6 (0–200) .86
IgA ASCA in CD 114.5 (2.9–200) 61.4 (0–200) .59
IgG ASCA in CD 87.3 (0–200) 68.2 (0–200) .41
(iii) IgE total and IgE speciﬁc for selected foods (milk,
wheat ﬂour, chicken, egg white and yolk)—
immunoﬂuorescent method (determination in
immunological reaction of chemiluminescence),
using reagents produced by DPC Krak´ ow (norm
for IgE total <87IU/mL, norm for food-speciﬁc IgE
<0.35KU/I).
The mutations R702W, G908R and L1007fs of gene
NOD2/CARD15 were determined in all examined children.
[13].
2.1. Ethical Issues. In order to conduct this study the
approval of the Bioethical Committee at the Medical Uni-
versity of Silesia in Katowice was obtained. All parents
received the information about the study and they gave their
written consent to participate. The informed consent was
also obtained from those children who were over 16 years of
age.
3. Results
3.1. Correlation between Clinical Phenotypes and Laboratory
Tests. IgE-dependent food allergy was found in 13 children
(32.5%) with ulcerative colitis and in 8 (21%) children
with Crohn’s disease. Although we did not ﬁnd statistically
signiﬁcant diﬀerences in the occurrence of food allergy
in children with ulcerative colitis and Crohn’s disease, it
is noticeable that atopy (IgE total) occurs more often in
children with Crohn’s disease, and allergy to particular foods
is more frequent among children with ulcerative colitis. In
the control group, the features of atopy in the form of increased
total IgE levels were found in 3 children (13%); none of these
children had speciﬁc IgE.
We did not ﬁnd the inﬂuence of food allergy on the clin-
ical picture of ulcerative colitis; however, we observed a ten-
dency towards a more frequent occurrence of inﬂammatory
changes in the duodenum with inﬂammatory inﬁltration
consisting of lymphocytes, plasmatic cells and eosinophils in
patients with Crohn’s disease and food allergy. We did notMediators of Inﬂammation 3
observe any relation between the occurrence of food allergy
and the frequency and ASCA titre (Table 1).
3.2. Immunologic Examination. We analyzed the presence of
antibodies p-ANCA (+)/ASCA(−) and p-ANCA (−)a n d
ASCA (+) in the group of children with allergic colitis and
we determined the presence of these antibodies in 47% of
patients. We found signiﬁcant diﬀerences in the frequency
and titre of ANCA and ASCA between particular groups
(Tables 2 and 3).
Statistically, antibodies against p-ANCA were signiﬁ-
cantly more frequent in the group of children with ulcerative
colitis in comparison with the control group. These antibod-
ieswerefoundin25%ofchildrenwithulcerativecolitis,10%
of children with Crohn’s disease and 17.5% of children with
allergic colitis. Sensitivity of p-ANCA for diagnosing UC
equals 25%, speciﬁcity (in relation to controls) was 100%.
We did not observe any relation between the occurrence
of p-ANCA and the clinical picture of ulcerative colitis and
allergiccolitis;inCrohn’sdiseasetheseantibodieswerefound
only in children with disease localization in large bowel.
The occurrence of ASCA antibodies (IgA and/or IgG)
was observed in 73.7% of children with Crohn’s disease,
17.5% with ulcerative colitis and almost 30% with allergic
colitis, statistically signiﬁcantly more frequent in children
with Crohn’s disease in comparison with the other examined
groups and controls. Statistically, patients with Crohn’s
disease and the presence of ASCA revealed a signiﬁcantly
more frequent localization of lesions within the small bowel
andatendencytowardsolderage(meanage15.5).Sensitivity
ASCA (IgG or IgA) for diagnosing Crohn’s disease was
determined as 73.7%, speciﬁcity (in relation to controls) was
91.3%.
Sensitivity of IgA ASCA for diagnosing Crohn’s disease
was determined as 57.9%, speciﬁcity (in relation to controls)
was 95.7%.
Sensitivity of IgG ASCA for diagnosing Crohn’s disease
was determined as 71.1%, speciﬁcity (in relation to controls)
was 95.7%.
3.3. Molecular Examination. In the group of children with
Crohn’s disease, 15 patients (39.5%) were carriers of at
least one mutation of CARD15 gene; among them the
most frequent was R702W mutation in 7 children (18.4%),
L1007fs mutation in 6 children (15.8%), the least frequent
was G908R mutation in 3 children (7.9%). We presented
the occurrence of ANCA and ASCA in relation to mutations
R702W, G908R, and L1007fs in the examined groups of
children. We observed a connection between the occur-
rence of antibodies and the examined mutations of gene
NOD2/CARD15 (Table 4).
4. Discussion
In the course of inﬂammatory bowel diseases like Crohn’s
disease, allergic and ulcerative colitis, the inﬂammatory
process results from disorders of the immune system regu-
lation. The mucosa becomes damaged due to a pathological
response of T lymphocytes, secreted cytokines and cytotoxic
activity of eﬀector cells. Th1 response with increased secre-
tion of TNFalpha, IFNgamma and other proinﬂammatory
cytokines is characteristic for the active phase of Crohn’s
disease, celiac disease and IgE-independent allergy (i.e., cel-
lular type). Whereas, in ulcerative colitis and IgE-mediated
allergy a predominant role is played by a subpopulation of
Th2, producing cytokines responsible for humoral type of
response with increased synthesis of antibodies, especially
IgE and IgG. In allergic colitis a more predominant type of
response is cellular one; however, the pathomechanism is not
completely established yet [14–16].
Eosinophilic inﬁltration in the large bowel is a common
change in many diseases, like classic IgE mediated food
allergy, allergic colitis or Inﬂammatory Bowel Disease. In
IBD eosinophils usually comprise a small percentage of
predominant lymphocytic inﬁltration, but their high level is
a predictor of unfavourable prognosis, since the products of
theirdegranulation,suchaseosinophilcationicprotein,have
a proinﬂammatory eﬀect and damage tissues; degranulation
of eosinophils was also observed in the course of IBD [17,
18]. At present, IgE-mediated and IgE-independent food
allergiesaretakeninto accountin thepathogenesis ofallergic
colitis. Eosinophilic inﬁltration of III degree according to
Whitington was found in our examined group in 4 children
with Crohn’s disease, in 2 with ulcerative colitis and in 6
with allergic colitis. It is known that food allergy occurs
in the course of Inﬂammatory Bowel Diseases especially
in children. IgE-mediated food allergy is more frequently
described in colitis ulcerative, probably in relation to the
described above pathomechanism of this disease, however,
it is also observed in patients with Crohn’s disease [19–21].
Perhaps in this group of patients IgE-independent allergy
occurs more frequently (like in allergic colitis). Among our
examined patients IgE-mediated allergy speciﬁc to particular
food was diagnosed in 21% of patients with Crohn’s disease
and in over 32% of patients with ulcerative colitis; the
features of atopy in the form of sole high IgE was found
twice more often in patients with Crohn’s disease, they are
probably connected with immunologic disorders occurring
in the course of disease; we obtained similar results in
the previously published studies [22]. Considerably lower
frequency of food allergy was observed by Bartukowa—
in 14.3% patients with Crohn’s disease and in 8.7% of
patients with ulcerative colitis [23]. We determined elevated
values of ASCA in 30% of patients with allergic colitis,
in 70% with Crohn’s disease and in 10% with ulcerative
colitis. Statistically, the values of ASCA were signiﬁcantly
higher in Crohn’s disease. In children with Crohn’s disease
a n df o o da l l e r g yw eo b s e r v e dat e n d e n c yt o w a r d sam o r e
frequent duodenitis. In 2 children with previously diagnosed
eosinophilic colitis and high titre of ASCA, after 6 and 12
months of disease duration we diagnosed Crohn’s disease.
Among children with allergic colitis and the presence of
ASCA antibodies, one child has a positive family history
towards Crohn’s disease, and in one child a severe course
of disease suggests a future development of Crohn’s disease,
in both patients we did not ﬁnd any mutations of gene
NOD2/CARD15. Anti Saccharomyces cerevisiae antibodies4 Mediators of Inﬂammation
Table 2: Comparison between the frequency of occurrence of ANCA and ASCA antibodies in groups.
Controls UC CD Allergy colitis P
pANCA (+) (%) — 25 10.5 17.6 .04∗
cANCA (+) (%) — 10 — — .04∗∗
IgA ASCA (+) (%) 4.3 7.5 57.9 17.6 <.00001∗∗∗
IgG ASCA (+) (%) 4.3 17.5 71.1 29.4 <.00001∗∗∗∗
ASCA IgG and/or IgA (%) 8.7 17.5 73.7 29.4 <.00001∗∗∗∗∗
Combinations ANCA and ASCA (%) <.00001∗∗∗∗∗∗
pANCA(+)ASCA(+) 0 2.5 5.3 0
pANCA(+)ASCA(−) 0 22.5 5.3 17.7
pANCA(−)ASCA(+) 8.7 15 68.4 29.4
pANCA(−)ASCA(−) 91.3 60 21.1 52.9
∗UC versus Ctrl, P = .01.
∗∗In exact Fisher’s test there are not any signiﬁcant relations while comparing groups in pairs.
∗∗∗CD versus Ctrl, P<. 00001; CD versus UC, P<. 00001; CD versus AC, P = .008.
∗∗∗∗CD versus Ctrl, P<. 00001; CD versus UC, P<. 00001; CD versus AC, P = .007.
∗∗∗∗∗CD versus Ctrl, P<. 00001; CD versus UC, P<. 00001; CD versus AC, P = .003.
∗∗∗∗∗∗Concerning combination pANCA(−)ASCA(+): CD versus Ctrl, P<. 00001; CD versus UC, P<. 00001; CD versus AC, P = .009.
Table 3: Comparison between titres of ANCA and ASCA antibodies in groups.
Controls UC CD Allergy colitis P
Titre (median, range) pANCA (+) 0 (0–3.8) 0 (0–27) 0 (0–14.4) 0 (0–6) .048∗
cANCA (+) 0 (0–0) 0 (0–10.4) 0 (0–3.3) 0 (0–4.2) .006∗∗
IgA ASCA (+) 5 (0–28.2) 6.8 (0–200) 62.7 (0–200) 7.1 (2.2–125) <.0001∗∗∗
IgG ASCA (+) 4.6 (0–36.3) 4.9 (0–200) 79.3 (0–200) 9 (0–90.6) <.0001∗∗∗∗
∗UC versus Ctrl, P = .03;
∗∗UC versus Ctrl, P = .03;
∗∗∗CD versus Ctrl, P = .000001; CD versus UC, P = .000001; CD versus AC, P = .0008.
∗∗∗∗CD versus Ctrl, P = .00003; AC versus Ctrl, P = .02; CD versus UC, P = .00008; CD versus AC, P = .007.
Table 4: The presence and titre of p-ANCA and ASCA in relation
to the occurrence of R702W/G908/L1007fs mutation in Crohn’s
disease.
Positive
mutation
N = 15
Lack of
mutation
N = 23
P
pANCA (+) (%) 6.7 13 1.0
IgA ASCA (+) (%) 73.3 47.8 .18
IgG ASCA (+) (%) 86.7 60.9 .14
ASCA IgG i/lub IgA (%) 93.3 60.9 .06
pANCA (+) – (median,
range) 0 (0–11.7) 0 (0–14.4) .36
IgA ASCA (+) –
(median, range) 200 (6.4–200) 18.7 (0–200) .09
IgG ASCA (+) –
(median, range)
150.9
(7.1–200) 34.9 (0–200) .01
are regarded as a serologic marker of Crohn’s disease; they
occur in 40–70% of patients, mainly in the form of disease
with the involvement of the small bowel and the early
onset of the disease (investigations were performed in adult
patients) [24, 25]. Similarly, in our studies we observed
a relation between ASCA antibodies occurrence and the
localization of disease in the small bowel; however, the
mean age of children with ASCA was higher (15.5 years) in
comparison with the group without these antibodies (11.5
years). Israeli et al. observed growing values of ASCA in
asymptomatic subjects in the period before establishing the
diagnosis of CD; ASCA were present in 31% of patients
before the diagnosis; the most often they appeared 36
monthsbeforethemanifestationofclinicalsymptoms.Israeli
suggests regarding the presence of ASCA to be an early
marker of the disease or a marker of immunologic response
to environmental antigens in the context of the early stage of
disease. The presence of ASCA in the high risk group may be
amarkerofCDdevelopmentandmayevenpredictitsclinical
course. Even asymptomatic patients with the presence of
ASCA should be monitored for CD [26]. ASCA are also
found in the course of diﬀerent diseases, like celiac disease.
So far the tests for the presence of anti ASCA antibodies in
patients with food allergy have not been made. The results
of production of ASCA are unknown. It is assumed that
increased permeability of the small bowel in patients with
Crohn’s disease may lead to increased exposure of yeast
antigens (which are a basic component of normal intestinal
ﬂora) to immunologic response cells. This hypothesis could
also explain the presence of ASCA in the course of celiac
disease and food allergy, which are inseparably connected
with increased permeability of the small bowel mucosa.
Basta observed the occurrence of ASCA in 30% of patientsMediators of Inﬂammation 5
with celiac disease, whereas Granito found ASCA in 59% of
patientswithceliacdisease,moreofteninclassIgG,andtheir
disappearance after introducing a gluten-free diet [27, 28].
He also discovered the presence of ASCA in several people
withlatentceliacdisease,withoutclinicalsymptoms(healthy
relatives), like Israeli did in the case of Crohn’s disease [14].
Granito formed a hypothesis that ASCA are a result of
nonspeciﬁc immunologic response to a prolonged damage
of the small bowel, and not a speciﬁc marker of Crohn’s
disease. In our study, titres of ASCA in children with food
allergy were signiﬁcantly lower than in Crohn’s disease and
they mainly occurred in class IgG. We did not observe a
more frequent occurrence of ASCA and ANCA antibodies in
children with food allergy in the course of Crohn’s disease
and ulcerative colitis nor a connection between food allergy
and ASCA and p-ANCA antibodies. Polymorphism of gene
NOD2/CARD15 is connected with the same phenotype of
the disease as ASCA; however, Halfarson did not ﬁnd any
connection between the three most important mutations
of gene CARD15 and the presence of ASCA [29, 30]. In
our examination we found a relation between the examined
mutations of gene NOD2/CARD15 and the presence of
antibodies. Similary Annese in a large group of patients
with Crohn’s disease proved a relation between mutation
NOD2/CARD15 and the localization in the small bowel, the
narrowing form of the disease and the early age of diagnosis,
but she also showed a relation between the mutation and the
presence of ASCA [31] .T h ep r e s e n c eo fA S C Ai si m p o r t a n t
forpatientswithundeterminedcolitis,however,50%ofthese
patients do not produce ASCA and p-ANCA.
The presence of ASCA+/ANCA− allows to predict
Crohn’sdiseasein80%ofpatientswithundeterminedcolitis,
and the pattern ASCA−/ANCA+ predicts ulcerative colitis in
64% of these patients [32–35].
The examined children in whom we diagnosed allergic
colitis, performing serologic examinations of ASCA and
ANCA, would allow to establish precisely the diagnosis in
almost half of children (47%). In several patients both the
clinical picture and the results of the other examinations
could suggest IBD from the very beginning, whereas the
majority of the examined children were qualiﬁed to the
group with allergic colitis with regard to normal param-
eters of inﬂammation and the absence of changes in
colonoscopy.
In the case of our children with allergic colitis it is not
known whether elevated ASCA titres are connected with the
small bowel damage, as Granito observed in celiac disease,
and they disappear after normalization of changes within the
small bowel, or maybe they are an early serologic symptom
of Crohn’s disease, as was observed by Israeli in the case of
diagnosed colitis. It seems that only a long-lasting clinical
and serologic observation of these patients will help to
establish the proper diagnosis.
5. Conclusions
We proved a high speciﬁcity of ASCA antibodies for Crohn’s
disease and p-ANCA for ulcerative colitis. We observed a
relation between the occurrence of ASCA antibodies and
localization in the small bowel, and a relation between p-
ANCA and localization in the large bowel in children with
Crohn’s disease, and also a connection between food allergy
and duodenitis in children with Crohn’s disease.
We did not prove any relation between ASCA antibodies
and the occurrence of food allergy in the examined groups of
children. In the course of allergic colitis, p-ANCA and ASCA
antibodies are present in almost half of children, which may
direct diagnosis towards ulcerative colitis or Crohn’s disease.
The performance of genetic and serologic examinations in
the group of children with colitis related to food allergy
allows to separate a group of patients requiring a strict
gastrological observation and control examinations in order
to establish the ﬁnal diagnosis of CD or UC.
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